Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis. [electronic resource]
Producer: 20111222Description: 253-63 p. digitalISSN:- 1742-1241
- Adult
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- economics
- Benzimidazoles -- economics
- Biphenyl Compounds
- Clinical Trials as Topic
- Cost-Benefit Analysis
- Drug Costs
- Female
- Heart Failure -- drug therapy
- Humans
- Hypertension -- drug therapy
- Losartan -- economics
- Male
- Middle Aged
- Quality-Adjusted Life Years
- Risk Factors
- Tetrazoles -- economics
- Young Adult
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.